Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic contrast-enhanced ultrasound to predict and assess rectal cancer response after neoadjuvant chemoradiation (RECT)
2016-002589-30Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sulfur hexafluoride in rectal cancer, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Area under the curve of intensity of the signal / time. Started Mar 2017; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2016-002589-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002589-30.